Skip to main content
Aprogen, Inc logo

Aprogen, Inc — Investor Relations & Filings

Ticker · 007460 ISIN · KR7007460009 KO Manufacturing
Open in API
Filings indexed 737 across all filing types
Latest filing 2022-05-27 AGM Information
Country KR South Korea
Listing KO 007460

About Aprogen, Inc

https://www.aprogen.com/en/v.do?a=Main

Aprogen, Inc. is a biopharmaceutical company focused on the research, development, and manufacturing of biologic medicines. The company's core activities are centered on developing both biosimilars and novel drugs, including new protein therapeutics and bispecific antibodies. Its product development is based on proprietary technologies in antibody engineering and recombinant protein engineering.

Recent filings

Filing Released Lang Actions
[기재정정]주주총회소집결의
AGM Information Classification · 98% confidence The document is a regulatory filing titled '주주총회소집결의' (Resolution for Convening a General Meeting of Shareholders) and a '정정신고' (Correction Report) regarding the date, time, and location of an Extraordinary General Meeting. It details the agenda items such as the approval of a merger agreement, appointment of directors, and changes to business objectives. This falls under the category of Proxy Solicitation & Information Statement (PSI) as it provides shareholders with the necessary information and meeting details to solicit their votes.
2022-05-27 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a 'Notice of Extraordinary General Meeting of Shareholders' (주주총회소집공고) for Aprogen Medicine. It includes the meeting agenda, date, location, and detailed management reference materials (경영참고사항) such as board activity, director remuneration, and business overviews. This type of document is provided to shareholders to inform them of upcoming votes and provide necessary background information, which is classified as a Proxy Solicitation & Information Statement.
2022-05-27 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled '의결권대리행사권유참고서류' (Reference Document for Solicitation of Proxy/Voting Rights) and is issued by (주)에이프로젠메디신. It provides detailed information regarding an upcoming Extraordinary General Meeting (EGM) to vote on a merger, including the purpose of the meeting, details of the merger, and instructions for shareholders to exercise their voting rights via proxy. This document is a standard proxy solicitation statement used to request shareholder votes for a specific corporate action, which falls under the 'Proxy Solicitation & Information Statement' category.
2022-05-27 Korean
[기재정정]주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) regarding the issuance of convertible bonds (전환사채권 발행결정) by Aprogen Medicines. It explicitly details amendments (정정신고) to the original filing, including changes to conversion prices, share issuance amounts, and the identity of the bond subscribers. This type of regulatory filing concerning capital structure and financing activities falls under the 'Capital/Financing Update' category.
2022-05-27 Korean
[기재정정]주요사항보고서(회사합병결정)
M&A Activity Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) regarding a corporate merger (회사합병 결정) between Aprogen Medicines and Aprogen. It details the merger ratio, valuation methods, and financial impact, which are standard components of a formal M&A announcement. Since this is a regulatory filing detailing a merger proposal and its terms, it falls under the M&A Activity category.
2022-05-17 Korean
[기재정정]증권신고서(합병)
M&A Activity Classification · 100% confidence The document is a 'Securities Registration Statement (Merger)' (증권신고서(합병)) filed with the Financial Supervisory Service (FSS) in South Korea. It details a 9th amendment (정정신고서) to a previously filed merger registration statement, including updates to merger timelines, financial projections, and share exchange ratios. This document is a formal regulatory filing related to M&A activity, specifically a registration statement for a merger, which falls under the 'M&A Activity' category.
2022-05-17 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.